Navigation Links
PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials
Date:8/20/2007

The article is available online at http://bloodjournal.hematologylibrary.org/cgi/content/abstract/blood-2007-0 6- 095646v1. The analysis will also be published in a future print edition of Blood.

About PNH

PNH is an acquired genetic blood disorder defined by hemolysis, in which patients' red blood cells are destroyed by complement, a component of the body's immune system. PNH is a rare disease that affects an estimated 8,000 to 10,000 people in North America and Europe.(13) PNH often strikes people in the prime of their lives, with an average age of onset in the early 30's.(3) Approximately ten percent of all patients first develop symptoms at 21 years of age or younger.(2) PNH develops without warning and can occur in men and women of all races, backgrounds and ages. PNH often goes unrecognized, with delays in diagnosis often ranging from one to more than 10 years.(4) The estimated median survival for PNH patients is between 10 and 15 years from the time of diagnosis.(13,4)

PNH has been identified more commonly among patients with disorders of the bone marrow, including aplastic anemia (AA) and myelodysplastic syndrome (MDS).(14,15,16,17) In patients with thrombosis of unknown origin, PNH may be an underlying cause.(2,18)

Prior to approval of Soliris, there were no therapies specifically available for the treatment of PNH. PNH treatment was limited to symptom management through periodic blood transfusions, non-specific immunosuppressive therapy and, infrequently, bone marrow transplantations -- a procedure that carries considerable mortality risk.(2,18)

About Soliris

Soliris was approved in March 2007 by the U.S. Food and Drug Administration (FDA) as the first treatment for PNH, a rare, debilitating and life-threatening blood disorder defined by hemolysis, or the destruction of red blood cells. In June 2007, the European Commi
'/>"/>

SOURCE Alexion Pharmaceuticals, Inc.

Copyright©2007 PR Newswire.

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Hematology Analyzers Simple, Sophisticated Technology Serving All Patients
2. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
3. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
4. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
5. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
6. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
7. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
8. TMC125 Showed Significant Virologic Response at Week 24 in Treatment-Experienced HIV Patients With NNRTI Resistance in Phase 3 Trials
9. Study Shows Ixabepilone Demonstrated Clear Activity in Patients with Metastatic Breast Cancer Resistant to Anthracycline, Taxane, and Capecitabine
10. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
11. Skin Rash Actually Signifies Better Outcomes for Pancreatic and Lung Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... DUBLIN , September 22, 2014 /PRNewswire/ ... ) has announced the addition of the  ... offering.       (Logo: http://photos.prnewswire.com/prnh/20130307/600769) ... used to wirelessly operate electronic gadgets such ... gaming consoles from a short line-of-sight distance. ...
(Date:9/22/2014)... 22, 2014 A study on ... recently added to Transparency Market Research,s database of market ... Analysis, Size, Share & Forecast (2011 - 2017)", the ... US$ 3.9 billion in 2011, would observe growth at ... period of the report), and end-up valuing US$ 4.8 ...
(Date:9/22/2014)... Mass. , Sept. 22, 2014 Decision Resources ... pharmaceutical market is expected to be worth $2 billion (U.S. ... percent over the next five years (to 2018). This growth ... of 4.8 percent in 2013 and 4.9 percent expected over ... pharmaceutical landscape is small but highly competitive. The pharmaceutical ...
Breaking Medicine Technology:Global Remotes Market 2014-2018 2Global Remotes Market 2014-2018 3Global Magnetic Resonance Imaging (MRI) Market Worth US $4.8 Billion by 2017: Transparency Market Research 2Global Magnetic Resonance Imaging (MRI) Market Worth US $4.8 Billion by 2017: Transparency Market Research 3Global Magnetic Resonance Imaging (MRI) Market Worth US $4.8 Billion by 2017: Transparency Market Research 4Despite Its Limited Size, Chile's Pharmaceutical Market Offers Growing Opportunity for Drug Industry 2Despite Its Limited Size, Chile's Pharmaceutical Market Offers Growing Opportunity for Drug Industry 3
... Del., March 20, 2012 Universal Capital Management, Inc. ... to purchase ProShield™ assets, a product owned by Seitz ... expected to be structured whereby the ProShield™ assets will ... of Universal, whose management team will include John Seitz, ...
... March 20, 2012  OriGene Technologies today announced the ... and extensively validated monoclonal antibodies under the UltraMAB™ ... antibodies which are exclusively developed by OriGene for ... products available on the market that have been ...
Cached Medicine Technology:Universal Capital Management Signs Letter of Intent to Purchase ProShield™ Assets 2Universal Capital Management Signs Letter of Intent to Purchase ProShield™ Assets 3OriGene Technologies Announces the Release Specificity-Verified UltraMAB™ Antibodies 2
(Date:9/22/2014)... News) -- All sexually active women should be ... transmitted infections: chlamydia and gonorrhea, according to new ... The task force noted this recommendation ... of age and pregnant women. Most women ... As a result, many infections go undetected. If ...
(Date:9/22/2014)... Steven Reinberg HealthDay Reporter ... that all children aged 6 months and older be vaccinated ... Pediatrics updated their influenza vaccine recommendations to advise that the ... build immunity. The AAP also wants parents of children aged ... spray vaccine instead of the flu shot if it,s readily ...
(Date:9/22/2014)... scientists have found that an anticonvulsant drug may help ... Although dozens of antibiotics target what bacteria do, their ... bacteria are created, and they found there is a ... important as there is growing concern worldwide about how ... The World Health Organization has declared that antibiotic resistance ...
(Date:9/22/2014)... 22, 2014 Quincy Bioscience, one ... States, promotes National Self-Improvement Month this ... individuals should have access to self-improvement resources, especially ... The demand for products that preserve health is ... before. For over six years, Quincy Bioscience has ...
(Date:9/22/2014)... (HealthDay News) -- Scans of young children,s brains ... This finding could potentially allow doctors to identify ... on, preliminary research suggests. "Early identification and ... as well as most neurodevelopmental disorders," the study,s ... of child and adolescent psychiatry at University of ...
Breaking Medicine News(10 mins):Health News:Screen Women for Chlamydia, Gonorrhea, Experts Say 2Health News:Pediatricians Urge Flu Vaccine for All Kids 6 Months and Older 2Health News:Pediatricians Urge Flu Vaccine for All Kids 6 Months and Older 3Health News:Quincy Bioscience Promotes National Self-Improvement Month 2Health News:Can Brain Scans Help Predict Young Children's Reading Abilities? 2
... 5 The National Association for Sport,and Physical ... new,partnership to help to educate, challenge, and encourage ... for a healthy and fit life. As,the new ... S&S Worldwide,will assist the nonprofit education association in ...
... Recent news reports,confirm that obesity rates continued to ... be surprising to learn that there are some foods ... of the general population and 18,percent of pregnant moms ... experts, including the American Heart Association (AHA) and,American Dietetic ...
... in Her Own Fluids ... Refuses to Evacuate Her, MIAMI, Sept. 5 A lawsuit ... on the Carnival Cruise,Lines ship, the Carnival Legend, committed medical malpractice ... of,medical care. Suit was filed by John H. (Jack) Hickey who ...
... to cardiovascular disease and type II diabetes is under ... study, which follows 523 pairs of twins, is funded ... Institutes of Health. , Cardiovascular disease and type ... challenge to the United States, says Dr. Frank Treiber, ...
... (Amex: PRZ ), one of the nation,s ... services, today announced that it has,successfully closed on ... which,owns and operates an ambulatory surgery center (ASC) ... Center, located in Coral Gables, Florida.,The completed sales ...
... Product to Enhance Patient Safety, Improve Efficiency, ... a $1,billion-plus global services firm that specializes in ... today announced,that it has been awarded a $1 ... a two- hospital, 619-bed regional health system,based in ...
Cached Medicine News:Health News:National Association for Sport and Physical Education Partners with S&S Worldwide to Help Improve Children's Fitness 2Health News:National Association for Sport and Physical Education Partners with S&S Worldwide to Help Improve Children's Fitness 3Health News:Eat Seafood, See Weight Loss: Recent Study Finds Another Reason to Eat Seafood for a Fit Lifestyle 2Health News:Medical Malpractice at Sea 2Health News:Environmental stress probed in cardiovascular disease, diabetes 2Health News:PainCare Receives $14.4 Million in Cash From Completed Sale of South Florida Ambulatory Surgery Centers 2Health News:PainCare Receives $14.4 Million in Cash From Completed Sale of South Florida Ambulatory Surgery Centers 3Health News:PainCare Receives $14.4 Million in Cash From Completed Sale of South Florida Ambulatory Surgery Centers 4Health News:Keane Wins $1 Million Electronic Medical Record (EMR) Implementation at New Jersey-Based Acute Care Facility 2Health News:Keane Wins $1 Million Electronic Medical Record (EMR) Implementation at New Jersey-Based Acute Care Facility 3
... Jenner Stain is used for staining ... one of the oldest stain formulations ... results similar to that of Giemsa ... appear brighter red; basophilic granules and ...
... Our Buffered Wright-Giemsa Stain ... that contains the fixative, buffer, ... convenient staining of blood smears. ... 32-oz. bottle for ease of ...
RABIT (Rapid Automated Bacterial Impedance Technique) has been developed by Don Whitley Scientific over several years with the aid of leading product and computer design consultants....
For the quantitative determination of Albumin in serum. Endpoint procedure with Amax at 630 nm. Linearity: to 6 g/dl. Liquid ready-to-use reagent....
Medicine Products: